Rare SLC13A1 variants associate with intervertebral disc disorder highlighting role of sulfate in disc pathology

• Published in: Health Research Policy and Systems
• Main Authors: DBDS Genetic Consortium, GO Consortium
• Other Authors: Office of Division of Diagnostic and Support Services, Faculty of Medicine, Faculty of Industrial Engineering, Mechanical Engineering and Computer Science, Faculty of Pharmaceutical Sciences, Internal Medicine and Emergency Services, Clinical Laboratory Services, Diagnostics and Blood Bank, Other departments, School of Health Sciences, Landspitali - The National University Hospital of Iceland
• Format: Article in Journal/Newspaper
• Language: English
• Published: 2022
• Subjects: Heila- og taugaskurðlæknisfræði; Gigtarlæknisfræði; Náttúrufræðingar; Intervertebral Disc Degeneration; Intervertebral Disc Displacement; Back Pain; Genome-Wide Association Study; Bone and Bones/metabolism; Intervertebral Disc/metabolism; Humans; Symporters/genetics; Sodium Sulfate Cotransporter/genetics; Sulfates/metabolism; Intervertebral Disc Degeneration/genetics; Intervertebral Disc Displacement/genetics; 3' Untranslated Regions; Physics and Astronomy (all); Chemistry (all); Biochemistry; Genetics and Molecular Biology (all); Iceland
• Online Access: https://hdl.handle.net/20.500.11815/3028; https://doi.org/10.1038/s41467-022-28167-1

Funding Information: We thank all participants in the various studies included here, for their valuable contribution to research. We thank all investigators and colleagues in Iceland who contributed to data collection, phenotypic characterization of clinical samples, genotyping and analysis of the whole-genome association data. We acknowledge participants and investigators of the FinnGen study in Finland, the DBDS-CHB studies in Denmark, and the UK Biobank in Great Britain. This research has been conducted using the UK Biobank Resource under Application Number 24898. The financial support from the European Commission to the painFACT project (H2020-2020-848099, T.E.T.) is acknowledged. K.B., T.F.H., and S.B. acknowledge the Novo Nordisk Foundation (grants NNF17OC0027594 K.B., T.F.H., S.B., and NNF14CC0001 K.B., T.F.H., S.B.). Funding Information: We thank all participants in the various studies included here, for their valuable contribution to research. We thank all investigators and colleagues in Iceland who contributed to data collection, phenotypic characterization of clinical samples, genotyping and analysis of the whole-genome association data. We acknowledge participants and investigators of the FinnGen study in Finland, the DBDS-CHB studies in Denmark, and the UK Biobank in Great Britain. This research has been conducted using the UK Biobank Resource under Application Number 24898. The financial support from the European Commission to the painFACT project (H2020-2020-848099, T.E.T.) is acknowledged. K.B., T.F.H., and S.B. acknowledge the Novo Nordisk Foundation (grants NNF17OC0027594 K.B., T.F.H., S.B., and NNF14CC0001 K.B., T.F.H., S.B.). Publisher Copyright: © 2022, The Author(s). Back pain is a common and debilitating disorder with largely unknown underlying biology. Here we report a genome-wide association study of back pain using diagnoses assigned in clinical practice; dorsalgia (119,100 cases, 909,847 controls) and intervertebral disc disorder (IDD) (58,854 cases, 922,958 controls). We identify 41 ...